Benign or malignant pulmonary lesions
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients with a peripheral pulmonary nodule or mass who need to undergo diagnostic bronchoscopy 2. 20 years old and above 3. Informed consent
Exclusion criteria
Exclusion criteria: 1. Case with serious concomitant medical illness 2. Central pulmonary lesions 3. Diffuse pulmonary lesions 4. Re-examination due to prior failure in this trial 5. Patients who need to undergo other bronchoscopic procedure (e.g. TBNA, BAL) 6. Bleeding tendency 7. Pregnant woman 8. Other clinical difficulties in this trial
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Diagnostic yield; according to lesion size, location, benign or malignant | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Frequency of adverse effects 2.Level of bronchus reached 3.Visibility on EBUS 4.Direct visibility of lesions with bronchoscope 5.Time of procedure | — |
Countries
Japan
Contacts
Nagoya Medical Center Department of Respiratory Medicine